Sales Medical Device

Terrence S. McGrath

**** ****** ***, ***** **

Longmont, CO 80501

****************@*****.***

Cell: 303-***-****

An innovative and energetic leader, skilled communicator/team builder, and

adept negotiator. Public company COO with diverse brand management and

business development background, experienced in multiple product categories

including consumer goods and medical devices. Expert at developing

technology, markets and development of strategic and tactical initiatives

that improve competitive performance while boosting revenues and profits.

. Initiated a plan to shift a plasma coatings company from an industrial

"job shop" to a high value-added medical device coating manufacturer with

unique technology. Included restructuring, redirected patent and product

strategies.

. Managed corporate transition from a personal products marketer to a

medical device research and development company. Completed two private

placements, licensing agreement for core technology, and corporate

acquisition.

. Turned $7 million annual loss into $5 million profit within fourteen

months for $100 million consumer products manufacturer.

. Created and launched first national marketing campaign for 30 year old

brand-reversed 7% annual distribution decline, grew profits 210%,

increased sales 37%.

. Devised and instituted strategic marketing plan that grew Klondike Ice

Cream Bar's sales 37% in one year. Won Popai DuPont award for innovative

retail display program and Effie for outstanding advertising campaign

results.

. Retail management experience includes direct sales forces, distributors,

brokers, and independent sales representatives.

CORPORATE EXPERIENCE

Elemetric LLC, Longmont CO. January 2008- Present

Private research company.

Partner - January 2008 - January 2009

Elemetric is engaged in the development of elemental bond control

technology which is applicable to a wide range of commercial applications.

Ionic Fusion Corporation, Longmont, CO. August 2005 to April 2007.

Private plasma physics company developing nano-engineered surfaces for

medical devices.

Chief Operating Officer - February 2006 to April 2007;

Corporate Vice President - August 2005 - January 2006.

IFC is a technology-enabled company with plasma physics technology applied

to medical device markets (e.g. surgical implants, orthopedic implants,

tools, sensors, external devices) and multiple segments within such markets

(e.g. cardiovascular, orthopedic, dental, burn/trauma). Leading the

transformation of Ionic Fusion as a non-focused job shop into a medical

device coating company. Transitioned Company through major shift in

leadership. Shifted the corporate business model to maximize shareholder

value. Initiated a new technology plan that developed high need-gap medical

device surfaces to leverage the company's core Ionic Plasma Deposition

technology. Company subsequently filed nine patent applications (cell

attachment, antimicrobial surfaces, UV activation, biosensors and protein

deposition) while raising $2.5 million in Round B funding. Company

relocated to Minneapolis in early 2007.

Hydron Technologies, Inc., Pompano Beach, FL. January 2000 - August 2005.

(NASDAQBB: HTEC.OB)

Publicly traded marketer of prestige skincare products and developer

of skin/organ oxygenation technology.

Chief Operating Officer - HTEC was a research and development company

concentrated on products and medical device applications utilizing its

patented tissue oxygenation and skin delivery technologies, and on

accumulating data for a Food & Drug Administration 510(k) application

related to this technology. Developed and patented a technology (method,

products and devices) for infusing oxygen back into to human skin, tissue,

and organs without the use of the bloodstream; includes numerous wound

care, medical, OTC and cosmetic skin care applications. Increased Hydron

catalog sales by 48% while reducing marketing expenses by over 50%. Co-

developed and patented a new ingredient delivery system and acne drug

delivery system. Initiated private label program to improve Hydron's cash

flow. Initiated and closed acquisition of Clinical Results Inc in just 2

months.

Independent Consumer Marketing Consultant, Fort Wayne, IN. 1992-1999.

Analyzed client companies' operations, products, and markets, then create

and implement new business development and marketing strategies. Client

base consists primarily of producers of consumer products for retail and

direct marketing. Initiated licensing in more than 8 categories.

Representative engagements have included: Balfour Company, Inc., Attleboro,

MA. Contributed significantly to turn this $100 million jewelry

manufacturer's $7 million loss into a $5 million profit in 14 months.

Redirected business and marketing strategies, launched licensed retail and

direct mail ring program, and developed divesture strategy of corporate

incentive business. Northwest Anti-Corrosion, Inc., Plains, MT. Grew sales

90% for this producer of industrial and automotive anti-corrosion products

into retail, industrial, military, and international channels. Developed

direct response commercial, utilizing Robin Leach as spokesperson. Edward

Billington Sugar, Ltd., Liverpool, UK. Founded company to import and market

a natural and organic sugar line under license into US market and achieved

placement in over 1900 stores. Consumer Direct, Yardley, PA. Established

business plans and secured manufacturing partners and marketing licenses

for consumer products. Created numerous properties including a skincare

line and jewelry licenses with Elite Models, Cosmopolitan magazine, and an

automotive line with Bobby Alison.

Pioneer Products, Inc., Ocala, FL. 1989-1992.

$31 million producer of Betty Crocker dessert decorations, specialty

foods and imported Schwartau preserves.

Vice President - Sales & Marketing Reported to President and German

owners. Direct reports included field sales force, customer service,

marketing, and packaging design groups. Developed programs for

distributors, brokers, and direct national accounts. Boosted Betty Crocker

licensed sales from $16 million to $25 million. Developed and implemented

first national marketing campaign, reversing 7% annual distribution decline

and growing profits 210% while increasing sales 37%. Reduced new

distribution acquisition costs 40%.

Schwartau Fruit Preserves: Transformed 6 consecutive annual losses into

profit within 5 months.

Isaly Klondike Company, Clearwater, FL. 1985-1989.

$83 million producer and distributor of ice cream products.

Vice President - Marketing, 1989 Reported to President.

Assistant, Vice President - Marketing, 1989

Marketing Director, 1985-1989.

Grew sales from $35 million to $83 million in 4 years. Developed and

implemented strategic marketing plan that boosted flagship Klondike Ice

Cream Bar's sales 37% in 1 year. Launched 4 new Klondike sub-brands.

Created and implemented freezer display program that won a Popai DuPont

award. Developed new advertising/media campaign that won an Effie award.

Noxell Corporation, Baltimore, MD. 1982-1985.

$300 million producer of Cover Girl Cosmetics, Noxzema Skin Products

and household products.

Senior Product Manager, 1984-1985;

Product Manager - Corporate Development, 1983-1984;

Product Manager - Toiletries/Cosmetics, 1982-1983.

Primary focus in business development. Identified and developed new areas

for corporate growth beyond core Cover Girl and Noxzema brands in over 14

categories. Created 4 new products in OTC drugs, including oral care,

deodorant, and liquid analgesic. Developed innovative processes that

reduced new product development time 50%.

Procter & Gamble Company, Cincinnati, OH. 1979-1982.

Assistant Brand Manager - Ivory Shampoo, 1981-1982; Sales Management

Trainee, 1981; Brand Assistant - Scope Mouthwash, 1979-1980.

EDUCATION

A.B., Princeton University, Princeton, NJ. 1979. Interdisciplinary study

with emphasis in Engineering. Intercollegiate engineering design award

winner. Psychology thesis on achievement motivation. Co-founded Princeton

University Furniture Agency.

Terrence S. McGrath

Cell: 303-***-****

2005 Calico Ct.

********@*********.***

Longmont, CO 80503

INTELLECTUAL PROPERTY

Five issued patents and seven pending applications in chemical bond

modeling and manipulation, metallic thin film medical device coatings, and

skin treatments.

Issued Patents

Controlled Phase Transition of Metals - 7,284,987

A technology for breaking metallic and chemical bonds with minimal

heat

ABSTRACT: A process for electromagnetic energy - induced solid to

liquid phase transitions in metals is disclosed. The method utilizes

coherent electromagnetic fields to transform solid materials such as

silicon and aluminum without detectable heat generation. The

transformed material reverts to a solid form after the electromagnetic

field is removed within a period of time dependent on the material and

the irradiation conditions.

Physical Quantum Model for the Atom - 7,284,987 (10/23/07)

A platform model for elemental bond control

ABSTRACT: A Quantum Model of the atom has been formulated, which

illustrates how classical wave structures and four-wave intersections

provide a background-independent supersymmetric metric of quantized

positions outward from the atom's single neutrino centerpoint. The

Quantum Model reveals the physical structure and the natural

regularization of low-energy lattice circle solutions as the basis for

quantum loops founded at Planck scales. Importantly, the Model

provides the causal structure for charge, confinement, the Higgs

mechanism, photons and gravity. The Quantum Model provides a unique

tool for teaching, demonstration, rendering, and experimentation

related to atomic level structures, field generation, bonding, and

elemental bond control.

Molecular Plasma Deposition of Colloidal Materials - 7,250,195

A platform technology for biosensors

ABSTRACT: A molecular plasma discharge deposition method for

depositing colloidal suspensions of biomaterials such as amino acids

or other carbon based substances onto metal or nonmetal surfaces

without loss of biological activity and/or structure is described.

The method is based on generating charged corona plasma which is then

introduced into a vacuum chamber to deposit the biomaterial onto a

biased substrate. The deposited biomaterials can be selected for a

variety of medical uses, including coated implants for in situ release

of pharmaceuticals.

Compositions and methods for emulsifier delivery system - 6,984,391

A new emulsification delivery system for acne ingredients and drugs

ABSTRACT: New cosmetic compositions are disclosed that are effective

both as moisturizers and skin sloughing agents. The compositions

contain neutralized weak organic acids that when applied over time to

the skin in appropriate formulations will gradually increase in

acidity to pH 5.5 or less, for example about pH 4.5, without causing

skin irritation while exhibiting increasing activity in skin renewal

effects.

Compositions and method of tissue superoxygenation for a medical device -

6,649,145

A method for adding oxygen back into skin and tissue topically for

burn and wound care

ABSTRACT: Disclosed are methods and compositions for increasing tissue

oxygen levels by administration of super-oxygenated compositions of

tissue surfaces. The methods are applicable to treatment of a wide

variety of conditions including burns, bedsores, ulcers, necrosis and

anaerobic infections.

Pending Applications

Photo Control of a Glucose Redox Reaction - 200********

A technology for on/off control of glucose biosensors for diabetes

management

ABSTRACT: Methods are described for modifying a redox reaction using

selected non-ionizing radiation. In a particular example, the

oxidation of glucose in the presence of glucose oxidase can be

completely inhibited when exposed to selected excited state

frequencies.

Modified surfaces for attachment of biological materials - 200********

A technology for controlling cell attachment on medical devices at the

nanoscale

ABSTRACT: The invention relates to bioactive surface coatings

deposited on selected substrates. Surface nanostructured film coatings

deposited on most metal or nonmetal substrates to provide surfaces can

be engineered to promote enhanced tissue/cell adhesion. Attached

cells, including osteoblasts, fibroblasts and endothelial cells,

retain viability and will readily differentiate and proliferate under

appropriate conditions. Fibroblasts and endothelial cells exhibit good

attachment and growth on most coated substrates, except on nano

surfaced structured silicone.

Ultraviolet Activated Antimicrobial Surfaces - 200********

A method for on-site activation of antimicrobial surfaces for medical

devices

ABSTRACT: The invention is directed to an ion plasma deposition method

adapted to coat polymer surfaces with highly adherent antimicrobial

films. A controlled ion plasma deposition process is used to coat a

metal or polymer with a selected metal/metal oxide. Exposing the

coated surface to ultraviolet light significantly improves the

antimicrobial properties of the deposited coatings.

Radiopaque Coatings for Polymer Substrates - 200********

A cost-effective method for achieving radiopacity even on ceramic and

plastic medical devices

ABSTRACT: Improved radiopaque coatings particularly suitable for

polymer substrates are described. A modified ion plasma deposition

method is used to provide coatings with macro particle-dense surfaces

that have excellent radiopacity. The coatings are particularly adapted

to polymer surfaces because of high adherence and resistance to

peeling and flaking.

Axial atomic model for determination of elemental particle field structure

and energy levels - 200********

A physical model of the atom useful for determining elemental bonding

structure and mechanisms

ABSTRACT: A six-dimensional axial Model of the atom which illustrates

elemental and particle field structure has been formulated. The Model

enables the determination of particle characteristics and interactions

so that energy levels can be manipulated because of insights into the

atom's axial structure, particle substructure and field generation.

Other applications pending

P-type Zinc Oxide

Contact this candidate